IN3 Investors Conference Paris
Presented today at IN3 Investors Conference in Paris on behalf of Cardiatis. I’ve got to admit, Cardiatis platform technology really rocks. Noureddine Frid, the lead entrepreneur and inventor has devevlop the first universally applicable endovascular aneurysm repair stent and the concept is testing well in clinical trials.
The presentation was simple this time, I covered the 5,000 year history of aneurysm repair in a couple of slides, explained how Cardiatis platform technology differs from current existing endovascular devices for aneurysm repair and then gave the coupe de grace:
“It is sufficient to say that in the field of aneurysm treatment Cardiatis is making history. We have a new answer to endovascular aneurysm repair and it is simple, it is elegant and it works.“
Quite an interest we generated among attending VCs and the industry brass. The Hilton was ok and Paris lovely as always.